Regenerative Medicine Market (Technology: Stem Cell, Biomaterial, and Tissue Engineering; and Application: Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Bones, Autogenic Bones, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Regenerative Medicine Market – Scope of Report
TMR’s report on the global regenerative medicine market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global regenerative medicine market for the period 2017–2028, considering 2018 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global regenerative medicine market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global regenerative medicine market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global regenerative medicine market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global regenerative medicine market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global regenerative medicine market.
The report delves into the competition landscape of the global regenerative medicine market. Key players operating in the global regenerative medicine market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global regenerative medicine market that have been profiled in this report.
Key Questions Answered in Regenerative Medicine Market Report
What is the scope of growth of product companies in the global regenerative medicine market?
What will be the Y-o-Y growth of the global regenerative medicine market between 2021 and 2028?
What is the influence of changing trends in technologies on the global regenerative medicine market?
Will North America continue to be the most profitable market for regenerative medicine devices providers?
Which factors are anticipated to hamper the growth of the global regenerative medicine market during the forecast period?
Which are the leading companies in the global regenerative medicine market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global regenerative medicine market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global regenerative medicine market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the regenerative medicine market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the regenerative medicine market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global regenerative medicine market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global regenerative medicine market more reliably and accurately.
Companies Mentioned
Smith & Nephew plc
Anika Therapeutics, Inc.
DePuy Synthes, Inc.
Baxter International, Inc.
Stryker Corporation
Medtronic, Inc.
Arthrex Inc.
Zimmer Holdings, Inc.
CONMED Corporation
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Regenerative Medicines Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Technology Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Regenerative Medicines Market Analysis and Forecast, 2017–2028
- 5. Key Insights
- 5.1. Technological Advancements
- 5.2. Key Mergers & Acquisitions
- 5.3. Regulatory Scenario by Region/globally
- 5.4. COVID-19 Pandemics Impact on Industry
- 6. Global Regenerative Medicines Market Analysis and Forecast, by Technology
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Technology, 2017–2028
- 6.3.1. Stem Cell
- 6.3.2. Biomaterial
- 6.3.3. Tissue Engineering
- 6.4. Market Attractiveness Analysis, by Technology
- 7. Global Regenerative Medicines Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017–2028
- 7.3.1. Bone Graft Substitutes
- 7.3.2. Osteoarticular Diseases
- 7.3.3. Allogeneic Bones
- 7.3.4. Autogenic Bones
- 7.3.5. Others
- 7.4. Market Attractiveness Analysis, by Application
- 8. Global Regenerative Medicines Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
- 9. North America Regenerative Medicines Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.2. Market Value Forecast, by Technology, 2017–2028
- 9.2.1. Stem Cell
- 9.2.2. Biomaterial
- 9.2.3. Tissue Engineering
- 9.3. Market Value Forecast, by Application, 2017–2028
- 9.3.1. Bone Graft Substitutes
- 9.3.2. Osteoarticular Diseases
- 9.3.3. Allogeneic Bones
- 9.3.4. Autogenic Bones
- 9.3.5. Others
- 9.4. Market Value Forecast, by Country, 2017–2028
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Technology
- 9.5.2. By Application
- 9.5.3. By Country
- 10. Europe Regenerative Medicines Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Technology, 2017–2028
- 10.2.1. Stem Cell
- 10.2.2. Biomaterial
- 10.2.3. Tissue Engineering
- 10.3. Market Value Forecast, by Application, 2017–2028
- 10.3.1. Bone Graft Substitutes
- 10.3.2. Osteoarticular Diseases
- 10.3.3. Allogeneic Bones
- 10.3.4. Autogenic Bones
- 10.3.5. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Italy
- 10.4.5. Spain
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Technology
- 10.5.2. By Application
- 10.5.3. By Country/Sub-region
- 11. Asia Pacific Regenerative Medicines Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Technology, 2017–2028
- 11.2.1. Stem Cell
- 11.2.2. Biomaterial
- 11.2.3. Tissue Engineering
- 11.3. Market Value Forecast, by Application, 2017–2028
- 11.3.1. Bone Graft Substitutes
- 11.3.2. Osteoarticular Diseases
- 11.3.3. Allogeneic Bones
- 11.3.4. Autogenic Bones
- 11.3.5. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Technology
- 11.5.2. By Application
- 11.5.3. By Country/Sub-region
- 12. Latin America Regenerative Medicines Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Technology, 2017–2028
- 12.2.1. Stem Cell
- 12.2.2. Biomaterial
- 12.2.3. Tissue Engineering
- 12.3. Market Value Forecast, by Application, 2017–2028
- 12.3.1. Bone Graft Substitutes
- 12.3.2. Osteoarticular Diseases
- 12.3.3. Allogeneic Bones
- 12.3.4. Autogenic Bones
- 12.3.5. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2017–2028
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Technology
- 12.5.2. By Application
- 12.5.3. By Country/Sub-region
- 13. Middle East & Africa Regenerative Medicines Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Technology, 2017–2028
- 13.2.1. Stem Cell
- 13.2.2. Biomaterial
- 13.2.3. Tissue Engineering
- 13.3. Market Value Forecast, by Application, 2017–2028
- 13.3.1. Bone Graft Substitutes
- 13.3.2. Osteoarticular Diseases
- 13.3.3. Allogeneic Bones
- 13.3.4. Autogenic Bones
- 13.3.5. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2017–2028
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Technology
- 13.5.2. By Application
- 13.5.3. By Country/Sub-region
- 14. Competition Landscape
- 14.1. Market Player – Competition Matrix (by tier and size of companies)
- 14.2. Market Share Analysis, by Company, 2020
- 14.3. Company Profiles
- 14.3.1. Smith & Nephew plc
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Financial Analysis
- 14.3.1.3. Growth Strategies
- 14.3.1.4. SWOT Analysis
- 14.3.2. Anika Therapeutics, Inc.
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Financial Analysis
- 14.3.2.3. Growth Strategies
- 14.3.2.4. SWOT Analysis
- 14.3.3. DePuy Synthes, Inc.
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Financial Analysis
- 14.3.3.3. Growth Strategies
- 14.3.3.4. SWOT Analysis
- 14.3.4. Baxter International, Inc.
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Financial Analysis
- 14.3.4.3. Growth Strategies
- 14.3.4.4. SWOT Analysis
- 14.3.5. Stryker Corporation
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Financial Analysis
- 14.3.5.3. Growth Strategies
- 14.3.5.4. SWOT Analysis
- 14.3.6. Medtronic, Inc.
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Financial Analysis
- 14.3.6.3. Growth Strategies
- 14.3.6.4. SWOT Analysis
- 14.3.7. Arthrex Inc.
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Financial Analysis
- 14.3.7.3. Growth Strategies
- 14.3.7.4. SWOT Analysis
- 14.3.8. Zimmer Holdings, Inc.
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Financial Analysis
- 14.3.8.3. Growth Strategies
- 14.3.8.4. SWOT Analysis
- 14.3.9. CONMED Corporation
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Financial Analysis
- 14.3.9.3. Growth Strategies
- 14.3.9.4. SWOT Analysis
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook